NGC - Search Results

Welcome to NGC. Skip directly to: Search Box, Navigation, Content.

NGC Search Results

Search Help | Guideline Comparison Help | Guideline Views | Quick Search Tips

Your search criteria:

Disease/Condition: "End stage renal disease"
Sort Order: Relevance

Your search found 27 related guidelines, which are listed below by relevance. Use the "Limit Search" button to sort by publication date.

To view a guideline summary, click on a title below.

Items 1 to 20

	Title
	Renal failure. American College of Radiology - Medical Specialty Society. 1995 (revised 2005). 8 pages. NGC:004615 Other Guidelines from this Developer
	Clinical practice guidelines for bone metabolism and disease in chronic kidney disease. National Kidney Foundation - Disease Specific Society. 2003 Oct. 201 pages. NGC:003312 Other Guidelines from this Developer
	Management of type 2 diabetes. New Zealand Guidelines Group - Private Nonprofit Organization. 2003 Dec. 143 pages. NGC:003363 Other Guidelines from this Developer
	Clinical practice guidelines for managing dyslipidemias in chronic kidney disease. National Kidney Foundation - Disease Specific Society. 2003 Apr. 91 pages. NGC:003133 Other Guidelines from this Developer
	Treatment of tuberculosis. American Thoracic Society - Medical Specialty Society Centers for Disease Control and Prevention - Federal Government Agency [U.S.] Infectious Diseases Society of America - Medical Specialty Society. 2003 Jun 20. 77 pages. NGC:003054 Other Guidelines from this Developer
	Prevention of progression of kidney disease: dietary protein restriction. Caring for Australasians with Renal Impairment - Disease Specific Society. 2006 Apr. 16 pages. NGC:005861 Other Guidelines from this Developer
	(1) KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. (2) 2007 update of hemoglobin target. National Kidney Foundation - Disease Specific Society. 1997 (updated 2006 May; addendum released 2007 Sep). Original guideline: 145 pages; addendum: 60 pages. NGC:006019 Other Guidelines from this Developer
	Specific management of IgA nephropathy: role of triple therapy and cytotoxic therapy. Caring for Australasians with Renal Impairment - Disease Specific Society. 2005 Sep. 11 pages. NGC:006136 Other Guidelines from this Developer
	Specific management of IgA nephropathy: role of tonsillectomy. Caring for Australasians with Renal Impairment - Disease Specific Society. 2005 Sep. 5 pages. NGC:006137 Other Guidelines from this Developer
	Specific management of IgA nephropathy: role of cyclosporine and other therapies. Caring for Australasians with Renal Impairment - Disease Specific Society. 2005 Sep. 8 pages. NGC:006138 Other Guidelines from this Developer
	Parathyroid hormone. Caring for Australasians with Renal Impairment - Disease Specific Society. 2006 Jan. 17 pages. NGC:006144 Other Guidelines from this Developer
	Micronutrient intake in children. Caring for Australasians with Renal Impairment - Disease Specific Society. 2005 Dec. 4 pages. NGC:006166 Other Guidelines from this Developer
	NKF-K/DOQI clinical practice guidelines for hemodialysis adequacy: update 2006. National Kidney Foundation - Disease Specific Society. 1997 (updated 2006 Jul). 85 pages. NGC:005329 Other Guidelines from this Developer
	NKF-KDOQI clinical practice guidelines for peritoneal dialysis adequacy: update 2006. National Kidney Foundation - Disease Specific Society. 1997 (updated 2006 Jul). 32 pages. NGC:005330 Other Guidelines from this Developer
	NKF-KDOQI clinical practice guidelines for vascular access: update 2006. National Kidney Foundation - Disease Specific Society. 1997 (updated 2006 Jul). 26 pages. NGC:005331 Other Guidelines from this Developer
	Guidance on home compared with hospital haemodialysis for patients with end-stage renal failure. National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.]. 2002 Sep (reviewed 2005). 20 pages. NGC:005404 Other Guidelines from this Developer
	Detection of chronic kidney disease in patients with or at increased risk of cardiovascular disease. A science advisory from the American Heart Association Kidney and Cardiovascular Disease Council; the Councils on High Blood Pressure Research, Cardiovascular Disease in the Young, and Epidemiology and Prevention; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: Developed in Collaboration With the National Kidney Foundation. American Heart Association - Professional Association National Kidney Foundation - Disease Specific Society. 2006 Sep 5. 5 pages. NGC:005478 Other Guidelines from this Developer
	Cinacalcet for the treatment of secondary hyperparathyroidism in patients with end-stage renal disease on maintenance dialysis therapy. National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.]. 2007 Jan. 28 pages. NGC:005508 Other Guidelines from this Developer
	VA/DoD clinical practice guideline for the management of diabetes mellitus. Department of Defense - Federal Government Agency [U.S.] Veterans Health Administration - Federal Government Agency [U.S.]. 1999 Dec (revised 2003 Sep). 147 pages. NGC:003567 Other Guidelines from this Developer
	Diabetic retinopathy. American Academy of Ophthalmology - Medical Specialty Society. 1998 Sep (revised 2003). 33 pages. NGC:003276 Other Guidelines from this Developer

Browse

» Disease / Condition
» Treatment / Intervention
» Measures
» Organization
» Guideline Index
» Guidelines In Progress
» Guideline Archive

Compare

» View My Collection
» Guideline Syntheses

Search
Browse
Compare
Resources

Date Modified: 9/15/2008